Advanced Search

Home > Journals > International Angiology > Past Issues > International Angiology 2016 April;35(2) > International Angiology 2016 April;35(2):212-6

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEINTERNATIONAL ANGIOLOGY

A Journal on Angiology

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899

Frequency: Bi-Monthly

ISSN 0392-9590

Online ISSN 1827-1839

 

International Angiology 2016 April;35(2):212-6

    ORIGINAL ARTICLES

A novel approach to infrainguinal arteries with chronic total occlusions using the high frequency vibrational device

Kimihiro IGARI, Toshifumi KUDO, Takahiro TOYOFUKU, Yoshinori INOUE

Division of Vascular and Endovascular Surgery, Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan

BACKGROUND: Endovascular treatment (EVT) for chronic total occlusion (CTO) is a technically challenging problem in peripheral arterial disease (PAD). The Crosser system is a CTO device with high frequency vibrational energy to cross the CTO, which has been adopted for coronary CTO. We performed EVT procedure by the device for PAD with CTO, and the purpose of this study was to evaluate the efficacy and safety of a high-frequency vibrational device, the Crosser™ system, in the EVT for the infrainguinal arteries with CTO.
METHODS: From April 2014 to September 2014, 16 patients with 19 sites of infrainguinal CTO underwent EVT with the Crosser™ system and technique. CTO was defined as 100% occlusion of the vessel, and technical success was defined as the device’s ability to facilitate the successful intraluminal delivery of the guidewire into the distal vessel. In addition, we evaluated the postoperative complications, including device-related complications.
RESULTS: We treated 16 patients (12 males; mean age, 68±7 years) with a mean lesion length of CTO of 150±85 mm. A technical success rate of 84% was achieved, and no device-related complications were observed, including dissection and perforation. Technical failure was associated with hemodialysis and calcification of grade 3 (P=0.029 and 0.047, respectively).
CONCLUSIONS: The Crosser™ system is a safe and effective treatment option for cases of infrainguinal CTO, without complications.

language: English


FULL TEXT  REPRINTS

top of page